Krishna Institute of Medical Sciences Ltd

NSE: KIMS · BSE: 543308 · Healthcare · 48 announcements

Share price: ₹722.00
Market cap: ₹30,324 Cr
Revenue (annual): ₹3,905 Cr
Net profit (annual): ₹241.4 Cr
P/E (TTM): 142.8×Sector 54.5×
Promoter holding: 32.66%+0.16% QoQ
FII holding: 15.01%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

4 Nov 2026 20:24 IST NSE

Krishna Institute of Medical Sciences Management Change

KIMS re-appointed Dr. Abhinay Bollineni as Director & CEO, Dr. Bhaskara Rao Bollineni as CMD, and Ms. Dandamudi Anitha as Whole-time Director. Terms start in 2027.

Execution: 5 years

Open announcement → Read the filing ↗

Krishna Institute of Medical Sciences Ltd by type

Other Announcement 7
Acquisition 7
Earnings Call 6
Board Meeting Date 4
Annual General Meeting 4
Capacity Expansion 3
Results Update 2
Financial Results 2
Partnership 2
Capital Structure Change 2
Fund Raise 2